We investigated the functional role of JP-45, a recently discovered protein of the junctional face membrane (JFM) of skeletal muscle. For this purpose, we expressed JP-45 C-terminally tagged with the fluorescent protein DsRed2 by nuclear microinjection in myotubes derived from the C2C12 skeletal muscle cell line and performed whole-cell voltage-clamp experiments. We recorded in parallel cell membrane currents and Ca 2+ signals using fura-2 during step depolarization. 
A rapid rise in intracellular Ca 2+ concentration activates force in skeletal muscle cells (Melzer et al. 1995; Bers, 2001) . Ca 2+ is stored in the terminal cisternae of the sarcoplasmic reticulum (SR) and buffered by the low-affinity, high-capacity Ca 2+ binding protein calsequestrin (CSQ). It is released under the control of the membrane potential of the transverse tubules (TTs), which conduct the action potential from the cell surface into the cell. The released Ca 2+ is bound by its target protein troponin C on the actin filament to induce force and is re-sequestered to the SR by the SR transport Ca 2+ ATPase. The Ca 2+ mobilization involves opening of ryanodine receptors (RyRs) in the membrane region of the terminal cisternae facing the TTs, termed 'junctional face membrane' (JFM). Voltage-dependent activation of dihydropyridine receptors (DHPRs) in the TT membrane leads to activation of the RyRs by conformational coupling across the junctional gap separating the JFM and TT. The α 1 -subunit of the DHPR serves as the voltage sensor in the Ca 2+ release process. It is currently thought that step depolarization in voltage-clamp experiments first rapidly activates a flux of Ca 2+ from the SR and then very slowly a Ca 2+ inward flux from the TTs (L-type Ca 2+ current) (Brum et al. 1987; Friedrich et al. 1999; Szentesi et al. 2001) . Both depend on the voltage-sensing properties of the DHPRs (Melzer et al. 1995) .
In addition to the main constituents of the Ca 2+ signalling process, a number of proteins with still ill-defined functions have been identified, which are associated with the α 1 -subunit of the DHPR in the TT membrane (Walker & De Waard, 1998; Arikkath & Campbell, 2003) or with the RyRs in the JFM (Caswell et al. 1991; Knudson et al. 1993; Guo & Campbell, 1995; Jones et al. 1995; MacKrill, 1999) . One of these proteins is a recently discovered constituent of the JFM with an apparent molecular mass of 45 kDa that has been termed JP-45 (Zorzato et al. 2000) . Co-localization of JP-45 and RyR1 has been indicated by an overlapping striation pattern in adult rat muscle fibres (Anderson et al. 2003) .
The protein contains 332 amino-acid residues and exhibits a single trans-membrane segment. The protein is highly charged, in particular the domain facing the SR lumen. The larger number of positively charged amino-acid residues makes it a basic protein. experiments demonstrated in vitro interaction with the DHPR and CSQ (Anderson et al. 2003) . This raises the question of whether JP-45 acts as a modulator of voltage-controlled Ca 2+ entry or Ca 2+ release. So far, no functional data are available and it is not known whether JP-45 exhibits interactions with components of the Ca 2+ release system in vivo. One approach to assess possible functional effects on muscle excitation-contraction (EC) coupling is the over-expression of the protein in normal muscle cells.
For the present experiments, we chose the skeletal muscle cell line C2C12. C2C12 myotubes show great similarities in Ca 2+ signalling to adult muscle fibres (Schuhmeier & Melzer, 2004; Ursu et al. 2005 ) and can therefore serve as a model system for mature EC coupling. We injected plasmids encoding fluorescent fusion proteins of JP-45 into the nuclei of C2C12 myotubes, observed the intracellular expression pattern and studied function (i.e. Ca 2+ inward current, gating charge movements and Ca 2+ release) under voltage-clamp conditions. The results suggest that JP-45 alters the voltage-controlled Ca 2+ permeability of the SR.
Methods

Cell culture
C2C12 cells, purchased from the American Tissue Culture Collection (ATCC, Manassas, VA, USA), were cultured in growth medium (Dulbecco's modified Eagle's medium, DMEM), supplemented with 10% fetal bovine serum as described by Schuhmeier et al. (2003) . To induce myotube formation and differentiation, cells were cultured in collagen-coated flasks containing DMEM supplemented with 2% horse serum. One day prior to experiments, myotubes were transferred from flasks onto collagen-and carbon-coated coverslips using a mild trypsin treatment.
Expression plasmids
The following plasmids were purchased from Clontech BD Biosciences (Heidelberg, Germany): pEGFP-C1, pDsRed2-N3 and pDsRed2-ER. pDsRed2-ER has been designed for fluorescent labelling of the endoplasmic reticulum (ER). A plasmid (pGFP-α 1C ) encoding the green fluorescent protein (GFP)-tagged α 1 -subunit of the cardiac L-type Ca 2+ channel (Ca V 1.2) (Grabner et al. 1998 ) was kindly provided by M. Grabner and B. E. Flucher (Innsbruck Medical University) .
The coding sequence of JP-45 (Anderson et al. 2003 ) was inserted 'in frame' into the red fluorescent protein coding vector pDsRed2-N3 and into the enhanced green fluorescent protein coding vector pEGFP-C1 resulting in plasmids encoding a C-terminally DsRed2-tagged JP-45, termed JP-45-DsRed2, and an N-terminally EGFP-tagged JP-45, termed GFP-JP-45. The plasmids were generated in Basel and shipped to Ulm for expression and functional testing.
Nuclear injection of plasmids
DNA solutions in sterile water (Aqua ad iniectabilia, Braun, Melsungen, Germany) were diluted to a final concentration of 0.125 μg μl −1 for pEGFP-C1 and pDsRed2-N3, to 0.25 μg μl −1 for pJP-45-DsRed2 and pEGFP-JP-45 and to 0.5 μg μl −1 for pGFP-α 1C (Beam & Franzini-Armstrong, 1997) . Injection capillaries (Femtotips, Eppendorf, Hamburg, Germany) were filled with the DNA solution and a commercial microinjection system (Injectman NI 2 micromanipulator and Femtojet pressure delivering device, Eppendorf) was used to inject into myotubes. Injections were performed into one nucleus per myotube by applying a 200-hPa pressure pulse of 0.3-s duration. A successful injection was indicated by a slight swelling and brighter appearance of the nucleus. Cells were placed in Hepes-buffered medium before performing injections; afterwards, the medium was exchanged for normal differentiation medium. Cells were voltage clamped 48 h later.
Confocal imaging
To image cells expressing fluorescent fusion proteins we used a Radiance 2000 confocal scanner (Bio-Rad, Hemel Hempstead, UK) adapted to an Eclipse TE300 inverted fluorescence microscope (Nikon). GFP fluorescence was excited by an Argon laser (488 nm) and filtered by an HQ 515/30 nm emission filter while for the DsRed2 fluorescence, a green He-Ne laser (543 nm) and an E 570 LP emission filter were used. The Argon and He-Ne lasers had nominal powers of 13 and 2.5 mW, respectively, and were used at 10-25% and 60-80% of their maximal power, respectively. Image acquisition was performed using LaserSharp 2000 (Bio-Rad).
Electrophysiology
The experimental solutions had the following compositions. External solution (mm): tetraethylammonium hydroxide (TEAOH) 130, HCl 127, CaCl 2 10, MgCl 2 1, 4-aminopyridine 2.5, glucose 5, tetrodotoxin (TTX) 0.00125 and Hepes 10; pH adjusted to 7.4 with HCl. Internal (pipette) solution (mm): CsOH 145, aspartic acid 135, EGTA 5, HCl 2, Hepes 10, CaCl 2 0.5 (free Ca 2+ , 10 −5 ), Na 2 ATP 0.84, MgATP 4.16 (Mg : ATP ratio (according to supplier), 1.4; free Mg 2+ , 1), sodium creatine phosphate 5 and K 5 -fura-2 0.2; pH adjusted to 7.2 with CsOH. The program CalcV22 (Föhr et al. 1993) was used to calculate the free ion concentrations in the internal solution.
Whole-cell patch-clamp experiments were performed at room temperature (20) (21) (22) (23) • C) as described by Schuhmeier et al. (2003) and Schuhmeier & Melzer (2004) . Cells expressing fluorescence from the marker proteins (see below) were further selected for compact shape suitable for single-electrode voltage clamping. Leak resistance and capacitance were determined by applying small positive and negative voltage steps (amplitude, 10 mV; duration, 25 ms) from the holding potential of −90 mV. Correction of residual linear current components (leak and capacitive) not compensated by the analog electronics was performed by using a control pulse from −90 to −110 mV applied 400 ms before each test pulse. Non-linear charge movements were determined by integrating the early transient outward component of the leak and linear capacitance-corrected current traces.
Current recordings I(V ) were normalized by the linear capacitance to obtain current densities i(V ). The voltage-dependence of the Ca 2+ current density i Ca (V ) was least squares-fitted with eqn (1) and eqn (2): (F 380 ) were recorded at 515 nm. After background correction, the F 380 recordings were normalized by measurements of fluorescence excited at 360 nm (F 360 ), which preceded each voltage-clamp activation as described by Schuhmeier et al. (2003) . The flux of Ca 2+ mobilization (Ca 2+ input flux) during depolarizations was calculated using a Ca 2+ -binding model (Schuhmeier & Melzer, 2004) . The model contained the indicator dye described by fluorescence ratio (R = F 380 /F 360 ) at zero dye saturation (R min ), ratio at full dye saturation (R max ), rate constants k on,Dye , k off,Dye and dye concentration [Dye] total , a saturating buffer (S) representing EGTA (parameters k on,S , k off,S and [S] total ) and an uptake mechanism (rate constant k uptake ).
[Dye] total and [S] total were set to values of 0.2 mm, and 5 mm, respectively. Traces generated with this model were least squares-fitted to the relaxation phases of consecutive voltage-activated fluorescence transients by optimizing the parameters k off,Dye , k on,S , k off,S and k uptake . For the determination of input flux, the free concentration of myoplasmic Ca 2+ and the estimated occupancies of the model compartments were summed and the time derivative calculated. Free Ca 2+ concentration was determined using background-and bleaching-corrected fura-2 fluorescence ratio signals and included reversal of the filtering effect resulting from the binding kinetics of the indicator (Klein et al. 1988) . For R min , R max and the dissociation constant of the dye (K Dye = k off,Dye /k on,Dye ) the following values were used: 2.84, 0.68 and 276 nm, respectively. Differential equations were solved using Euler's method. Recordings were smoothed by a digital filter that adjusts its bandwidth automatically to the signal dynamics (for a detailed description of the procedures see Schuhmeier et al. 2003 and Melzer, 2004) .
General analysis and statistics
General calculations and non-linear curve fitting were performed using Excel (Microsoft). Data are presented and plotted as means ± s.e.m. (n = number of experiments) for averaged values, if not indicated otherwise. To compare average values of two independent data sets, Student's t test was used to identify statistically significant differences (P = 0.05).
Results
C2C12 myotubes for functional expression studies in EC coupling
In the present study we used C2C12 cells to investigate effects of the junctional face protein JP-45 on voltagedependent Ca 2+ signalling in myotubes. C2C12 myotubes express characteristic muscle proteins (Blau et al. 1983) and show voltage-activated Ca 2+ inward current and Ca 2+ release flux similar to adult skeletal muscle cells (Schuhmeier et al. 2003; Schuhmeier & Melzer, 2004) .
For heterologous expression of proteins in C2C12 myotubes, we initially examined two frequently applied transfection methods, using calcium phosphate precipitation and Fugene 6 (Roche). Subsequently we tried nuclear injection of the cDNA-carrying plasmids. The effectiveness was tested with mammalian expression J Physiol 572.1 plasmids encoding the fluorescent proteins EGFP and DsRed2 (pEGFP-C1 and pDsRed2-N3, respectively). Of the three methods tested, nuclear injection led to the highest efficiency. The percentage of injected cells expressing the fluorescent marker varied between 10% and 75%. Expression started earlier (∼6 h) compared to cDNA-carrier transfection (∼24 h). We therefore used the nuclear injection for all experiments presented in this study.
Examples of myotubes expressing EGFP and DsRed2, respectively, are shown in Fig. 1A and B. Both fluorescent proteins exhibited a rather homogeneous distribution in the cytoplasm, as expected for soluble proteins. Figure 1C shows the result of injecting the plasmid pDsRed2-ER designed for fluorescent labelling of the endoplasmic reticulum (ER) in living cells. The DsRed2-ER subcellular marker is composed of the targeting signal sequence of calreticulin, the DsRed2 fluorescent protein coding sequence and the KDEL retention signal of calreticulin (Barton & MacLennan, 2004) . The KDEL sequence is recognized by receptors, present in vesicular tubular clusters of the ER and the Golgi apparatus, that capture soluble ER resident proteins and carry them back to the ER (Pelham, 1998) .
In our C2C12 myotubes, DsRed2-ER labelled a network distributed throughout the cytoplasm, which was denser in the vicinity of the nucleus (Fig. 1C) . A similar 'net-like' pattern of fluorescence expression was seen when pEGFP-JP-45 (Fig. 1D ) or pJP-45-DsRed2 (Fig. 1E) were injected. This is consistent with JP-45 being expressed in ER membranes as indicated by Anderson et al. (2003) for COS-7 cells transfected with pEGFP-JP-45. To obtain further information on the subcellular distribution of JP-45, we coinjected pEGFP-JP-45 and pDsRed2-ER. At 12 h after injection, green and red fluorescence were found to be colocalized in the vicinity of the injected nucleus (not shown). However, later (at 18 and 48 h), the fluorescent patterns were different from each other (Fig. 1F) . Previous studies suggest that the ER is transformed during differentiation into the functionally distinct SR through gradual replacement of generic ER proteins with specific SR proteins (Villa et al. 1993; Sanger et al. 2004) . Our observations are consistent with JP-45 being generated in the ER and then being targeted to specialized regions of this compartment, whereas DsRed2-ER is retained in the original ER by the KDEL retrieval system.
Test for functional expression
The imaging results described above indicated strong heterologous protein expression in the C2C12 myotubes after nuclear plasmid injection. In addition, we performed tests with a construct of well-defined function to verify that the degree of fluorescence expression that we achieved leads to sufficient functional expression. For this purpose, we injected pGFP-α 1C that encodes a fluorescent fusion protein of the α 1 -subunit of the cardiac L-type Ca 2+ channel (Ca V 1.2). These channels exhibit rapid activation kinetics so that their current can be easily distinguished from the very slowly activating current generated by the intrinsic Ca V 1.1 channels (see for example Schuhmeier et al. 2005) . Figure 2A shows a C2C12 myotube that had been injected with the pGFP-α 1C plasmid 2 days before imaging. The expression of fluorescent GFP-α 1C occurred later in time (2 days) than GFP alone (∼6 h) due to its much larger size (217 versus 27 kDa) and showed a particulate pattern and a final localization predominantly near the periphery of the cell.
The expression of the green fluorescence from GFP-α 1C was accompanied by a significant change in the inward current that could be recorded from the myotubes ( Fig. 2B and C). In the control cells (Fig. 2B) , the endogenous Ca 2+ current showed its typical slow activation and no inactivation during the pulse. The currents of the pGFP-α 1C -expressing cells (Fig. 2C) were larger, became considerably more rapidly activated and showed some degree of inactivation during the pulse. Figure 2D shows the mean voltage dependence of current density at the peak of activation in non-injected control cells ( e ) and in pGFP-α 1C -expressing cells (•). Figure 2E shows the voltage dependence of the activation kinetics as determined by a single exponential fit between 5 and 50 ms during the pulse for GFP-α 1C -expressing cells (•) and between 20 and 100 ms for control cells ( e ). On average, at +30 mV (i.e. close to the voltage that produces the maximum inward current) the amplitude was 2.6-fold larger in pGFP-α 1C -expressing myotubes and the time constant of activation was 12-fold smaller (data see legend). Thus, Fig. 2 confirms that our procedure allows substantial functional over-expression of even large proteins within the available time frame.
L-type Ca 2+ current in JP-45 over-expressing cells
Whole-cell patch-clamp experiments were subsequently carried out on myotubes injected with plasmids encoding a fluorescent JP-45 fusion protein. In parallel to the Ca 2+ currents, intracellular fura-2 Ca 2+ transients were recorded as described by Schuhmeier & Melzer (2004) . We chose DsRed2 as the marker protein (plasmid pJP-45-DsRed2) which exhibits red-shifted fluorescence spectra compared to fura-2. Myotubes injected with pDsRed2-N3, encoding DsRed2 alone, served as controls. Figure 3A and B shows examples of Ca 2+ inward current recordings from two myotubes expressing DsRed2 and JP-45-DsRed2, respectively. Figure 3C showed a significant difference. The best fit parameters are listed in the figure legend to Fig. 3 . Figure 3D shows the voltage dependence of the activation time constant obtained from single exponential fits to the activation phase of the slow inward current for both DsRed2-and JP-45-DsRed2-expressing cells ( e and •, respectively). As with current amplitude, no significant difference at any of the investigated voltages could be found.
JP-45 effects on Ca 2+ release
Each of the cells was analysed using a removal model fit procedure (originally described by Melzer et al. 1986 ). Briefly, this method quantifies Ca 2+ binding and reuptake parameters of the cell by fitting model-generated traces to the measured fluorescence ratio traces during the time after repolarization (for more details see Schuhmeier & Melzer, 2004) . Table 1 lists the mean values of the free kinetic parameters that were adjusted in the removal model to describe the relaxation phases of Ca 2+ transients for four consecutive voltage pulses of different duration and amplitude. The table shows that the mean values estimated here were similar to data obtained in non-injected myotubes by Schuhmeier & Melzer (2004) . Notably, the kinetic data obtained for the indicator dye and for the slow saturable model component S that was included to simulate EGTA were not significantly different. A statistically significant difference from the previous analysis was observed in the rate constant describing slow uptake (k uptake ) which might be due to a different pump rate in the present population of cells. Because there were no significant differences in the removal properties of test (JP-45-DsRed2) and control cells (DsRed2) Figure 4Ab shows a representative fura-2 fluorescence ratio signal obtained during a single application of a 100-ms depolarizing pulse to +30 mV (Fig. 4Aa) . The signal is drawn inverted in sign so that a rise in Ca 2+ is upward. The amplitude of the transient was determined by calculating the difference between the average of 20 baseline points and the average of the last six points of the pulse. Figure 4B shows the mean amplitudes at different voltages for both DsRed2-( e ) and JP-45-DsRed2-expressing (•) myotubes. In the latter set of cells the amplitude was significantly smaller compared to the controls. Figure 4Ac shows the conversion of the fluorescence signal to calcium input flux according to Schuhmeier & Melzer (2004) by using the results of the removal analysis. The arrows in Fig. 4Ac indicate the peak of the flux and the plateau, which is reached after the rapid inactivation. Both are plotted as functions of voltage in Fig. 4C and D. As in Fig. 4B , the mean values at +10 mV and above differed significantly in the two groups of cells (except for voltages of +20 and +60 mV).
The sigmoidal voltage dependence in Fig. 4C (peaks) was fitted for each individual experiment using a standard Boltzmann equation described by maximum amplitude (A max ), V 0.5 and k. In Fig. 4D (plateau) an additional term (as described by Schuhmeier & Melzer, 2004 ) was added to correct for the gradual decrease in amplitude at large depolarizations. The continuous activation curves in Fig. 4C and D were calculated using the mean values of the individual fit parameters. Comparing the results for JP-45-DsRed2-expressing myotubes with the controls, there was a significant decrease by 42% for the peak and 44% for the plateau in the parameter describing maximal J Physiol 572.1 activation at large depolarizations. All other parameters were not significantly different (see the legend to Fig. 4) .
A typical feature of the calculated Ca 2+ input flux traces was a slowly declining plateau (Fig. 4Ac and Fig. 5A ). In mature muscle, the slope of the plateau has been attributed to progressive SR Ca 2+ depletion at constant Ca 2+ release permeability (Schneider et al. 1987; Gonzalez & Rios, 1993; Ursu et al. 2005) . If the initial SR content is known, one can calculate the changes in SR Ca 2+ content from the estimated Ca 2+ release flux and correct the flux for SR Ca 2+ depletion. This leads to an estimate of the voltage-activated SR Ca 2+ permeability. Under the given assumption, the initial SR Ca 2+ content can be determined as the value that eliminates the slope in the plateau region when performing the correction. The procedure is demonstrated in Fig. 5 for a series of flux traces obtained at different voltages in a single myotube. At voltages lower than +10 mV, kinetics were slower and the separation between the fast and slow phases of decay (putative inactivation and depletion, respectively) became less obvious in most cells. Therefore, we used the value for SR Ca 2+ content determined at +10 mV also for depletion correction at voltages below +10 mV. For correction of the flux traces at +10 mV and above, we used the individually determined initial values for SR Ca 2+ content as described for experiments on adult mouse fibres by Ursu et al. (2005) . Figure 6A and B show the mean results of flux and permeability calculation at +30 mV for all JP-45-DsRed2-and DsRed2-(larger amplitude trace) expressing cells, respectively. The shaded area represents the point-by-point calculated s.e.m. While the fluxes Figure 5 . Estimation of Ca 2+ permeability from Ca 2+ input flux Correction of Ca 2+ input flux traces (A) for putative changes in SR Ca 2+ content at different voltages in a pDsRed2-N3-injected myotube to calculate permeability (B). For the depolarizations to +10 mV and more positive voltages, the plateau region of the fluxes in A was analysed individually as described in the Results to estimate the initial SR Ca 2+ content that leads to zero slope during the plateau after correction. The fluxes at the two lowest voltages were corrected using the value of SR Ca 2+ content estimated at +10 mV. (Fig. 6A) showed different time courses due to the faster relative decline during the plateau of the traces with larger amplitudes, permeabilities (Fig. 6B ) exhibited a very similar time course.
We performed this 'depletion analysis' with the experiments of Fig. 4 . Because this procedure is sensitive to any noise disturbing the determination of the slope in the plateau, we had to exclude one recording at +20 mV for DsRed2-expressing cells.
The mean values of the estimated SR Ca 2+ contents are shown in Fig. 6C . The values of mean initial SR Ca 2+ content at different voltage varied between 1.21 and 1.81 mm and showed no significant difference between JP-45-expressing cells and the controls. Figure 6D and E shows the voltage dependence of the corrected peak and plateau permeabilities, respectively. Unlike the SR Ca 2+ content, the permeabilities show significant differences: in Fig. 6D , values at −10, 0, +10 and +30 mV are significantly different and in Fig. 6E , all values above −20 mV (except for the +20 mV value) are significantly different. Figure 6F shows the ratio of peak/plateau, a frequently used measure to characterize the overall shape of the traces. It is essentially constant over the voltage range of activation and not significantly different for JP-45-DsRed2-expressing cells and controls.
To check whether the reduction in voltage-activated Ca 2+ permeability resulted from a loss of functional voltage sensors, we analysed the non-linear capacitive current at the onset of the depolarization as an estimate of the DHPR gating charge movements. Figure 7A and B shows the mean values of charge density at different voltages for myotubes expressing DsRed2 and JP-45-DsRed2, respectively. Consistent with the DHPR-mediated L-type Ca 2+ current data, no significant difference was found between the two groups of experiments at any voltage. The data were fitted with conventional Boltzmann functions resulting in maximal charge density (q max ) values of 10.0 ± 1.3 × 10 −3 and 13.0 ± 2.4 × 10 −3 C F −1 for DsRed2-and JP-45-DsRed2-expressing cells, respectively. The V 0.5 values were 5.1 ± 1.9 and 6.4 ± 2.1 mV, and the k values 13.1 ± 1.8 and 9.9 ± 1.2 mV (n = 12 and n = 11), respectively (comp. eqn (2)). A previous study (Zheng et al. 2002a) obtained mean values of q max , V 0.5 and k of 6.52 C F −1 , 18.7 mV and 14.7 mV, respectively, for control C2C12 myotubes. Note that q max values given in this reference were erroneously scaled up 10-fold (Zheng et al. 2002b and O. Delbono, personal communication) . Ca 2+ release flux or Ca 2+ permeability as a function of the corresponding voltage-sensor charge movement is commonly referred to as the transfer function of EC coupling (e.g. Csernoch et al. 1999) . Figure 7C and D show transfer functions using the permeability data of Fig. 6 and the corresponding gating charge densities. Consistent with the lower permeabilities, the transfer functions of the JP-45-DsRed2-expressing cells (Fig. 7C and D, •) exhibited considerably lower steepness for both peak (Fig. 7C ) and plateau permeability (Fig. 7D) . The average slopes were 84.3 ± 27.0 versus 180.9 ± 40.5% ms (n = 6 versus n = 11, P = 0.063) and 39.1 ± 12.5 versus 97.0 ± 21.2% ms −1 C −1 F (P = 0.033), respectively. These results indicate that the differences in the amplitudes of Ca 2+ transients and Ca 2+ flux observed here (Fig. 4) resulted from differences in the activated permeation pathway and not from differences in either the Ca 2+ gradient that drives the flux or in voltage-sensor properties.
Discussion
In the present study, we searched for possible functional effects of the recently discovered JFM protein To study Ca 2+ release, we used an adapted version of the removal model fit approach first described by Melzer et al. (1986) . The values of the binding rate constants identified with this analysis were remarkably similar to those of our J Physiol 572.1 previous investigation in C2C12 myotubes (Schuhmeier & Melzer, 2004) (Schneider et al. 1987; Gonzalez & Rios, 1993) estimates the SR Ca 2+ content prior to the pulse (Ca 0,SR ) and corrects the release flux for the putative changes in SR Ca 2+ content determined from the flux and its slope during the slow phase. The values of Ca 0,SR estimated in our experiments for DsRed2-and JP-45-DsRed2-expressing myotubes averaged over the voltage range +10 to +80 mV (1.60 ± 0.23 and 1.47 ± 0.27 mm, respectively) were not significantly different from each other indicating that loading of the SR was not changed.
In voltage-clamped rat and mouse muscle fibres, values of 1.9 and about 3 mm, respectively, have been determined for Ca 0,SR using the same method (Shirokova et al. 1996 ; Figure 7 . Intramembrane charge movements and EC coupling transfer functions A and B, voltage dependence of charge density in cells expressing DsRed2 (A, n = 12) and JP-45-DsRed2 (B, n = 11). Continuous curves are Boltzmann functions fitted to the data. C and D, transfer functions; that is, peak Ca 2+ permeability (C) and plateau permeability (D) plotted against the corresponding charge density. DsRed2-expressing myotubes (n = 11), e ; JP-45-DsRed2-expressing myotubes (n = 6), •. Continuous curves are straight lines through the origin fitted to the mean values. Ursu et al. 2005) . It should be noted that Ca 0,SR is expressed in concentration with respect to the myoplasmic water volume, as is the release flux. An estimate of the SR volume in relation to myoplasmic water volume would be required (but is not available for myotubes) to convert the numbers to true concentrations in the SR. On the other hand, permeabilities (in % ms −1 ) and fractional changes of SR Ca 2+ content are independent of such morphometric data and therefore permit a comparison with data obtained from adult muscle fibres. For the peak permeability values in control myotubes, we obtained about 1.4% ms −1 at +50 mV in the present study compared to about 6% ms −1 at the same potential in mouse interosseus fibres . We determined that a 100-ms voltage pulse that maximally activates Ca 2+ release leads on average to about 50% reduction in the SR Ca 2+ content of the control (i.e. DsRed2-expressing) C2C12 myotubes. This compares to about 80% in mature mouse fibres estimated by a very similar analysis procedure . Because under the present conditions we found no evidence for altered charge movements, we suspect that the expression levels reached in our case are below the values needed to affect charge movements significantly. Nevertheless, our study showed a reduction in the Ca 2+ signals and in the calculated flux of Ca 2+ mobilization. The lower effectiveness of voltage-sensor charge movements in activating SR permeability, indicated by the reduced slope of the EC coupling transfer functions (Fig. 7C and D) , may have resulted from an inhibiting effect on the transmission from the DHPR caused by the interaction of the N-terminal region of JP-45 with the DHPR (Anderson et al. 2003) . Alternatively, it may have resulted from an interaction of the luminal C-terminal end of JP-45 with CSQ, as demonstrated in vitro (Anderson et al. 2003) . This interaction might affect the Ca 2+ storing properties in the lumen of the SR by altering the buffer capacity of CSQ. Yet, our analysis of Ca 0,SR (see above) showed no evidence for a reduced Ca 2+ concentration in the SR. In heart muscle, three proteins of the JFM (i.e. RyR, triadin and junctin) form a complex with CSQ that seems to influence the open probability of the RyR as a function of the Ca 2+ concentration in the SR lumen (Zhang et al. 1997; Györke et al. 2004) . In this complex, CSQ has been proposed to serve as a Ca 2+ sensor that modulates the RyR via links formed by triadin and junctin. A similar complex appears to be present in skeletal muscle (Beard et al. 2005) and may serve equivalent regulatory functions that may be altered by JP-45. Even though this indirect mechanism cannot be ruled out, in our opinion it is less likely than a more direct effect of JP-45 on functional domains of the DHPR relevant for Ca 2+ release control. JP-45 is specific for skeletal muscle SR. Therefore based on our results, it seems likely that JP-45 down-regulates the multiprotein EC coupling complex of the terminal cisternae in a manner specific to skeletal muscle. Consequently, loss of function by mutations in JP-45 may lead to skeletal muscle-specific pathological over-activity of the Ca 2+ release system. Mutations in RyR1 that lead to increased Ca 2+ release are known to cause malignant hyperthermia susceptibility (MHS) or central core disease (CCD). Therefore it seems worthwhile to screen the sequence of human JP-45 for mutations in those families with MHS or CCD with no known RyR1 mutations (Jurkat-Rott et al. 2000; Lyfenko et al. 2004) . Further important clues about the role of the protein can be expected from experiments similar to the ones shown here performed on myotubes or adult muscle fibres of genetically altered mice lacking JP-45.
In summary, we demonstrated, using plasmids encoding fluorescent fusion proteins, that efficient and rapid protein expression can be achieved in C2C12 myotubes by nuclear microinjection. Fusion constructs of JP-45, a protein of the skeletal muscle SR junctional face, expressed strong fluorescence in a cellular membrane compartment distinct from the ER portion labelled by DsRed2-ER. Using fura-2 fluorimetry under whole-cell voltage-clamp conditions, we found that JP-45-DsRed2-expressing C2C12 myotubes exhibited a decrease in depolarization-induced Ca 2+ transients while Ca 2+ inward current density was unaltered. Using a procedure to determine Ca 2+ flux and permeability from the Ca 2+ transient, the change could be tentatively assigned to an effect on the Ca 2+ permeability of the SR rather than its Ca 2+ content. Because in vitro studies had demonstrated binding of JP-45 to both the DHPR and calsequestrin, the observed effect on Ca 2+ release may be attributed to a modulatory effect of either one of these interactions.
